BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11076655)

  • 1. Expression of the novel tumour suppressor p33(ING1)is independent of p53.
    Cheung KJ; Bush JA; Jia W; Li G
    Br J Cancer; 2000 Dec; 83(11):1468-72. PubMed ID: 11076655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
    Cheung KJ; Mitchell D; Lin P; Li G
    Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
    Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
    Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner.
    Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K
    Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes.
    Gujuluva CN; Baek JH; Shin KH; Cherrick HM; Park NH
    Oncogene; 1994 Jul; 9(7):1819-27. PubMed ID: 8208528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M; Ozaki T; Todo S; Nakagawara A
    Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis.
    Helbing CC; Veillette C; Riabowol K; Johnston RN; Garkavtsev I
    Cancer Res; 1997 Apr; 57(7):1255-8. PubMed ID: 9102209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas.
    Kichina JV; Zeremski M; Aris L; Gurova KV; Walker E; Franks R; Nikitin AY; Kiyokawa H; Gudkov AV
    Oncogene; 2006 Feb; 25(6):857-66. PubMed ID: 16170338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
    Chen B; Campos EI; Crawford R; Martinka M; Li G
    Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.
    Shinoura N; Muramatsu Y; Nishimura M; Yoshida Y; Saito A; Yokoyama T; Furukawa T; Horii A; Hashimoto M; Asai A; Kirino T; Hamada H
    Cancer Res; 1999 Nov; 59(21):5521-8. PubMed ID: 10554029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53.
    Komarova EA; Diatchenko L; Rokhlin OW; Hill JE; Wang ZJ; Krivokrysenko VI; Feinstein E; Gudkov AV
    Oncogene; 1998 Sep; 17(9):1089-96. PubMed ID: 9764819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor ING1: structure and function.
    Cheung KJ; Li G
    Exp Cell Res; 2001 Aug; 268(1):1-6. PubMed ID: 11461112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
    Garkavtsev I; Kazarov A; Gudkov A; Riabowol K
    Nat Genet; 1996 Dec; 14(4):415-20. PubMed ID: 8944021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes.
    King KE; Ponnamperuma RM; Yamashita T; Tokino T; Lee LA; Young MF; Weinberg WC
    Oncogene; 2003 Jun; 22(23):3635-44. PubMed ID: 12789272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes.
    Cotton J; Spandau DF
    Radiat Res; 1997 Feb; 147(2):148-55. PubMed ID: 9008206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
    Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
    Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ING1 expression in sporadic breast cancer.
    Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
    Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.